To starve pancreatic tumors, researchers seek to block 'self-eating,' other fuel sources

April 13, 2018

CHAPEL HILL -- To get the extra energy they need to fuel their uncontrolled growth, cancer cells break down some of their own parts for fuel - a process known as autophagy, or "self-eating." Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center found a possible therapeutic strategy to block self-eating in one of the deadliest cancers, as well as to cut off the tumor's other energy sources.

The researchers are reporting preclinical findings for a potential two-treatment strategy to block multiple mechanisms of cancer cell metabolism in pancreatic cancer at the American Association for Cancer Research Annual Meeting in Chicago. The findings will be presented from 8 a.m. to noon on Wednesday.

"We know that cancer cells have a greater need for energy than normal cells," said UNC Lineberger's Channing Der, PhD, Sarah Graham Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology.

"They get their energy by changing normal metabolic processes to allow them to generate more energy, and one of these processes is self-eating. Basically what a cancer cell does is it does this more efficiently than a normal cell."

In other studies, pancreatic cancer cells have been known to rely more heavily on autophagy, but UNC Lineberger scientists reported evidence that a type of treatment -- an ERK inhibitor -- actually increased their reliance on this. The researchers believe the compound prevents the cell from relying on other energy sources, driving it toward autophagy.

"The cancer cell has many ways to achieve what it wants in terms of getting more energy," Der said. "We find that if you try to stop one, a cancer cell has the ability to compensate. I think the analogy many of us use is the 'whack-a-mole' concept where you knock one thing down, and something else pops up. We need more than one hammer basically."

To block multiple energy sources at once, the researchers used an ERK inhibitor to cut off these other energy sources, alongside with an investigational compound used to block autophagy, in the hopes of starving the cells completely. They reported at AACR that this co-treatment showed a synergistic effect.

"What if we could cripple more than one energy sources for the cell at once?" Der said.
-end-


UNC Lineberger Comprehensive Cancer Center

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.